Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Anna Loengard, M.D. to the Company's Board of Directors.

Dr. Anna Loengard Joins Clover Health Board of Directors

AMC Preferred Equity Unit

Arrival Group

ATI Physical Therapy

Bird Rides

Party City Holdco

Penny stocks are much riskier than your average investment. After all, you don't typically have a share price below $5 without some problems, be it a failing business plan, poor execution by management, etc.

6 Penny Stocks to Sell Right Now

Bed Bath & Beyond

Bakkt Holdings

FuboTV

MicroVision

Nikola

Skillz

The explosive stock market rally seen on Nov. 10 may have invited some investors to start thinking this downturn is coming to a close. However, before you make the move from “risk-off” to “risk-on,” there are certainly concerns to consider.

7 Penny Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole

The heavy selling pressure might have exhausted for Clover Health Investments, Corp. (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Down 22.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Clover Health Investments, Corp. (CLOV)

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 48.39% and 3.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Vivek Garipalli - Chief Executive Officer Andrew Toy - President Scott Leffler - Chief Financial Officer Conference Call Participants Jason Cassorla - Citi Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Whit Mayo - SVB Securities. Operator Please stand-by, your program is about to begin.

Clover Health Investments, Corp. (CLOV) Q3 2022 Earnings Call Transcript

Carvana

Opendoor

Peloton

Redfin

Teladoc

Zoom Video

This vicious bear market has spared very few firms in 2022. The S&P 500 has slipped more than 23% so far and it increasingly feels that things are getting worse.

7 Stocks Only Suckers Will Own In This Bear Market

FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that for the 2021 measurement year, the Centers for Medicare and Medicaid Services (“CMS”) has rated its PPO Medicare Advantage (“MA”) plan at 3.5 stars and increased the rating of its HMO MA plan from 3 stars to 3.5 stars on the Medicare Star Ratings. Currently, over 90% of Clover's MA membership is served through its PPO plan.

Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023

FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that it will report third quarter 2022 financial results after market close on Monday, November 7, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results.

Clover Health to Report Third Quarter 2022 Financial Results on November 7, 2022

FRANKLIN, Tenn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity for seniors, today debuted its 2023 Medicare Advantage (“MA”) plans, which are built to increase access to affordable, high-quality healthcare for Medicare eligibles across the country. The company also announced the launch of the LiveHealthy Rewards Program for its members, which aims to promote health literacy and encourage members to routinely engage with preventive primary care services by providing rewards for the completion of specified health-related activities.

Clover Health Debuts New Medicare Advantage Plans for 2023

Clover Health (NASDAQ: CLOV ) is losing its sponsor and must fly on alone. Chamath Palihapitiya, the “SPAC King” who brought CLOV stock public in early 2021 at about $16 per share (it's now at $1.86), has cut his stake in the Medicare Advantage provider to less than 5%.

Is Chamath Palihapitiya Giving Up on Clover Health (CLOV) Stock?

Aurora Innovation

Beyond Meat

Core Scientific Inc

CohBar

Matterport

Mullen Automotive

As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500.

7 Nasdaq Stocks to Sell Before They Die

CLOV could be in trouble if it does not turn the DC segment around in the next few quarters. With limited cash on hand and losses continuing to accumulate, I don't see how the company will be able to expand its operations without additional funding.

Rethinking My Clover Health Position

FRANKLIN, Tenn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 9:10 a.m. Eastern Time.

Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022

AMC Entertainment

GEO Group

Rivian Automotive

Snap

TravelCenters of America

Considering how markets have been moving so far this year, you might feel that meme stocks are a thing of the past. Once the markets take a bullish turn, though, expect the retail trading frenzy to feature again.

7 Meme Stocks for Investors to Take Seriously in 2022

CLOV likely overestimated the value of CA software, creating a hype among meme traders that has now subdued. Bearish mutual funds are in control of the stock price, but recent momentum could be an indicator of a loosening grip.

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Source: Wirestock Creators / Shutterstock Clover Health (NASDAQ: CLOV ) stock is falling on Tuesday after the company announced changes are coming to its leadership team. The big news affecting Clover Health today is CEO Vivek Garipalli leaving the role at the end of the year.

Clover Health (CLOV) Stock Sinks on Leadership Change Announcement

Clover Health Investments Corp (NASDAQ:CLOV ) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Ryan Schmidt - IR Vivek Garipalli - Co-Founder, CEO & Chairman Andrew Toy - Co-Founder, President, & Director Mark Herbers - Principal Accounting Officer Conference Call Participants Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Merrill Lynch Jason Cassorla - Citigroup Benjamin Mayo - SVB Securities Gary Taylor - Cowen and Company Operator Ladies and gentlemen, good afternoon, and welcome to the Clover Health Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Clover Health Investments Corp (CLOV) CEO Vivek Garipalli on Q2 2022 Results - Earnings Call Transcript

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 4.35% and 0.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Investments, Corp. (CLOV) Reports Q2 Loss, Lags Revenue Estimates

Shares of Clover Health Investments Corp. CLOV, +4.29% , which offers insurance plans to Medicare Advantage members, were off more than 6% in after-hours trading Monday after the company delivered a mixed earnings report and disclosed that its chief executive would be stepping down from that post at year's end. The company posted a net loss of $104.2 million, compared with a loss of $317.6 million a year earlier.

Clover Health stock drops after mixed earnings, announcement of impending CEO change

Second quarter total revenue was $846.7 million compared to $412.5 million in second quarter 2021

Clover Health Reports Second Quarter 2022 Financial Results

Vivek Garipalli to transition the role of CEO to Co-Founder and President Andrew Toy effective January 1, 2023; Mr. Garipalli to continue with Clover as Executive Chairperson moving forward Vivek Garipalli to transition the role of CEO to Co-Founder and President Andrew Toy effective January 1, 2023; Mr. Garipalli to continue with Clover as Executive Chairperson moving forward

Clover Health Announces Evolution of Leadership Roles to Best Support Future Growth

SmileDirectClub

AMC Entertainment Holdings, Inc (NYSE: AMC) surged about 25% at one point on Monday as the stock continued to trade higher in its uptrend, which Benzinga pr

As AMC Enters Bull Cycle, SmileDirectClub, Clover Health Move In Uptrends: What To Watch With The 3 Stocks

FRANKLIN, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022, at 2:00 p.m. Eastern Time.

Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022

The Clover Assistant shows MCR improvement with continued use. Clover Health is expanding in states accounting for a large part of nation's Medicare Advantage enrollment.

News for Clover Health Investments Stock (CLOV)